128 related articles for article (PubMed ID: 11277206)
1. Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis.
Mense MG; Van De Verg LL; Bhattacharjee AK; Garrett JL; Hart JA; Lindler LE; Hadfield TL; Hoover DL
Am J Vet Res; 2001 Mar; 62(3):398-405. PubMed ID: 11277206
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of immunopathophysiological responses induced by B. melitensis and its lipopolysaccharide in mouse model infected via intranasal route of exposure.
Osman AY; Saharee AA; Jesse FF; Kadir AA
Microb Pathog; 2017 Sep; 110():365-374. PubMed ID: 28710016
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of inhalational brucellosis in BALB/c mice.
Henning LN; Gillum KT; Fisher DA; Barnewall RE; Krile RT; Anderson MS; Ryan MJ; Warren RL
Sci Rep; 2012; 2():495. PubMed ID: 22773944
[TBL] [Abstract][Full Text] [Related]
4. Impaired control of Brucella melitensis infection in Rag1-deficient mice.
Izadjoo MJ; Polotsky Y; Mense MG; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2000 Sep; 68(9):5314-20. PubMed ID: 10948160
[TBL] [Abstract][Full Text] [Related]
5. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
Bhattacharjee AK; Izadjoo MJ; Zollinger WD; Nikolich MP; Hoover DL
Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
[TBL] [Abstract][Full Text] [Related]
6. Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein.
Bhattacharjee AK; Van de Verg L; Izadjoo MJ; Yuan L; Hadfield TL; Zollinger WD; Hoover DL
Infect Immun; 2002 Jul; 70(7):3324-9. PubMed ID: 12065469
[TBL] [Abstract][Full Text] [Related]
7. An aerosolized Brucella spp. challenge model for laboratory animals.
Olsen SC; Waters WR; Stoffregen WS
Zoonoses Public Health; 2007; 54(8):281-5. PubMed ID: 17894637
[TBL] [Abstract][Full Text] [Related]
8. Deletion of purE attenuates Brucella melitensis infection in mice.
Crawford RM; Van De Verg L; Yuan L; Hadfield TL; Warren RL; Drazek ES; Houng HH; Hammack C; Sasala K; Polsinelli T; Thompson J; Hoover DL
Infect Immun; 1996 Jun; 64(6):2188-92. PubMed ID: 8675325
[TBL] [Abstract][Full Text] [Related]
9. Pathologic changes associated with brucellosis experimentally induced by aerosol exposure in rhesus macaques (Macaca mulatta).
Mense MG; Borschel RH; Wilhelmsen CL; Pitt ML; Hoover DL
Am J Vet Res; 2004 May; 65(5):644-52. PubMed ID: 15141886
[TBL] [Abstract][Full Text] [Related]
10. TceSR two-component regulatory system of Brucella melitensis 16M is involved in invasion, intracellular survival and regulated cytotoxicity for macrophages.
Li Z; Fu Q; Wang Z; Li T; Zhang H; Guo F; Wang Y; Zhang J; Chen C
Lett Appl Microbiol; 2015 Jun; 60(6):565-71. PubMed ID: 25721466
[TBL] [Abstract][Full Text] [Related]
11. Modelling the immunopathophysiology of Brucella melitensis and its lipopolysaccharide in mice infected via oral route of exposure.
Osman AY; Kadir AA; Jesse FF; Saharee AA
Microb Pathog; 2019 Nov; 136():103669. PubMed ID: 31445124
[TBL] [Abstract][Full Text] [Related]
12. Comparative experimental study of Brucella melitensis and its lipopolysaccharide in mouse model infected via subcutaneous route of exposure.
Osman AY; Saharee AA; Jesse FF; Kadir AA
Microb Pathog; 2018 Mar; 116():318-327. PubMed ID: 29412161
[TBL] [Abstract][Full Text] [Related]
13. A study on the use of male animal models for developing a live vaccine for brucellosis.
Izadjoo MJ; Mense MG; Bhattacharjee AK; Hadfield TL; Crawford RM; Hoover DL
Transbound Emerg Dis; 2008 May; 55(3-4):145-51. PubMed ID: 18405337
[TBL] [Abstract][Full Text] [Related]
14. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
[TBL] [Abstract][Full Text] [Related]
15. Nasal vaccination stimulates CD8(+) T cells for potent protection against mucosal Brucella melitensis challenge.
Clapp B; Yang X; Thornburg T; Walters N; Pascual DW
Immunol Cell Biol; 2016 May; 94(5):496-508. PubMed ID: 26752510
[TBL] [Abstract][Full Text] [Related]
16. Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant.
Petrovska L; Hewinson RG; Dougan G; Maskell DJ; Woodward MJ
Vet Microbiol; 1999 Feb; 65(1):21-36. PubMed ID: 10068125
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
[TBL] [Abstract][Full Text] [Related]
18. Immuno-pathophysiological responses of mouse model to experimental infection with Brucella melitensis and its lipopolysaccharides via intraperitoneal route.
Osman AY; Abdullah FFJ; Kadir AA; Saharee AA
Microb Pathog; 2016 Nov; 100():17-29. PubMed ID: 27591112
[TBL] [Abstract][Full Text] [Related]
19. Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis.
Edmonds MD; Cloeckaert A; Elzer PH
Vet Microbiol; 2002 Sep; 88(3):205-21. PubMed ID: 12151196
[TBL] [Abstract][Full Text] [Related]
20. Pathological changes, distribution and detection of
Mazlan M; Khairani-Bejo S; Hamzah H; Nasruddin NS; Salleh A; Zamri-Saad M
Vet Q; 2021 Dec; 41(1):36-49. PubMed ID: 33349157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
